WinHealth and Immedica enter agreement giving Winhealth rights to Ravicti® in China and several other Asia-Pacific countries ...Middle East

STOCKHOLM and HANGZHOU, China, Dec. 30, 2020 /PRNewswire/ -- Hongkong WinHealth Pharma Group CO., Ltd and Immedica Pharma AB, today announce that they have entered an agreement under which WinHealth gains the exclusive commercial rights to Ravicti® (glycerol phenylbutyrate), in a...

Hence then, the article about winhealth and immedica enter agreement giving winhealth rights to ravicti in china and several other asia pacific countries was published today ( Thursday 31/12/2020 - 04:45 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( WinHealth and Immedica enter agreement giving Winhealth rights to Ravicti® in China and several other Asia-Pacific countries )

Also on site :

• The Supreme Court Cast Its Lot With Trumpism. It Should Be Very Worried.
• My Wife Doesn’t Know I Watched Her Cheat On Me. My Reaction Might Shock Us Both.
• Eight fire crews tackling blaze at West Midlands Wetherspoon pub